Big sci-tech ideas: from lab to marketplace
Published 27-SEP-2016 15:18 P.M.
|
3 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
A non-invasive diagnostic test to improve IVF success rates and an electronic nose that can detect illegal trafficking of wildlife contraband are just two of the big ideas announced today to be fast-tracked through the nation’s sci-tech pre-accelerator, ON Prime.
ON Prime is part of the ON program, powered by CSIRO and designed to create connections between research, science and business.
More than 160 researchers from across Australia registered for ON Prime.
The 39 successful teams will be armed with the skills to not only validate their science and technology ideas in the lab, but also in the marketplace.
CSIRO Chief Executive Dr Larry Marshall said he knew the big ideas were out there, but was overwhelmed by the quality of applications and appetite for entry across the research sector.
“We’re thrilled to have created this program for Australia’s research sector and can’t wait to see the breakthroughs that come from this round of ON Prime,” Dr Marshall said.
“The potential impact these ideas will have on the everyday lives of Australians and our economic, social, and environmental prosperity is huge.
“I’m most excited about the role we can play in connecting these teams with the mentors, customers and commercialisation experts who can help convert their ideas to real-world impact at pace.
“We know the pathway from great research to commercial outcomes is tough work and that’s why the ON experience is so critical and timely.
“It pools all that expertise and connections into a concentrated program that is focused on bridging the gap from benchtop to beta.
“This will help us tackle some of our nation’s greatest challenges.”
The teams commenced the eight-week program in one of five ON Prime ‘hubs’ across the country on 20 September, supported by funds provided through the National Innovation and Science Agenda.
Research teams collaborates with industry to fast-track big ideas through the ON accelerator.
Some of the big ideas that will be fast-tracked through ON Prime include:
- An acoustic-belt that listens to, records and analyses gut noises to aid more accurate diagnosis and treatment of patients suffering from irritable bowel syndrome or other gastrointestinal conditions
- A new tool for winemakers that captures and interprets historical, real-time and forecast data to help improve decision making and increase wine quality and crop outputs across the $300bn wine industry
- New contrast imaging technology that improves X-ray image sensitivity and quality and allows doctors to ‘see the invisible’ in tumours and soft-tissue while reducing the radiation dose for patients
- An empathy simulator that allows high-quality, cost-effective virtual training of health and aged care workers to improve communication skills and empathy
- New processes for apple juice producers to reduce or reuse the by-products of juice manufacture to create new food-products and markets while reducing landfill and greenhouse gas-emissions.
Shari Forbes from the ‘NOS.E: electronic nose’ team at the University of Technology Sydney said they were thrilled to be accepted into ON Prime and were looking forward to meeting with their mentors and commercialisation experts.
“We’re confident our science is valid and the impact it can have is huge, but what we’ve been missing is the deep network of industry partners and potential customers to test and validate the idea in the market,” Professor Forbes said.
“That’s what ON Prime brings to the table in a focused course format and that’s what we’re most excited about tapping into.”
Applications for ON Accelerate – the ON experience designed to build market validated ideas and develop and test business models – will open on 4 October 2016 with 10 positions available for research teams across the country.
About ON, powered by CSIRO
CSIRO launched the ON accelerator in July 2015 as part of its Strategy 2020, designed to boost Australia’s innovation performance by creating connections between disciplines, sectors, science and business. www.csiro.au/on
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.